6-Year-Old Celebrates Taking His Last Chemo Pill In Times Square After 4-Year Battle With Cancer

by Kelly Glass
Kelly Glass is a writer whose work focuses on the intersections of parenting, health, and pop culture. She lives in an Illinois college town with her educator husband, wildly ambitious sons, dog, and several fish. Her work has appeared in the Washington Post, Romper, BlackGirlNerds.com, HelloGiggles, Oxygen.com, What to Expect, and more.

King Singh was diagnosed with acute lymphocytic leukemia, a blood cancer, when he was just 2 years old.

Not long after, he was also diagnosed with a rare genetic blood disorder. Now he’s celebrating taking his last chemo pill.

“He is the strongest kid that we know. We could not be happier this journey is coming to an end,” said his overjoyed mom. King has remained positive and high-spirited in spite of it all. King eventually became an advocate for cancer awareness, participating in fundraisers and research and support charities. Now, at the age of 6, he celebrated taking his last chemo pill — after his three-and-a-half-year battle. 

King was in great spirits among family and friends in New York City’s Times Square. Sitting on his dad’s shoulders, the brave 6-year-old opened wide to show the world as he took in the last pill and opened once more to show it was no longer there. It was a huge celebration of victory for King. 

He was also in the presence of members of NYPD Hope, a fairly new program that welcomes with open arms sick and terminally ill children into its family, making them honorary members. “We are the luckiest people in the world to learn the lessons we get from kids like this young warrior,” said NYPD Officer Anthony Passaro, wishing King the best on his life after this remarkable recovery journey. 

Watch the video below to see King celebrate this milestone and to hear more about the NYPD program that gives brave kids like Singh the opportunity to become honorary NYPD officers.

Footage provided by WPIX New York


Due to restrictions, this video cannot
be viewed in your region.